期刊文献+

GPS评分对预测肝内胆管结石合并肝内胆管癌肝切除术的预后价值 被引量:3

Prognostic value of the Glasgow Prognostic Score in patients with hepatolithiasis-associated intrahepatic cholangiocarcinoma
下载PDF
导出
摘要 目的探讨术前Glasgow预后分数(Glasgow prognostic score,GPS)与肝内胆管结石合并肝内胆管癌(hepatolithiasis-associated intrahepatic cholangiocarcinoma,HLAIHCC)术后预后之间的关系。方法回顾性分析接受根治性肝切除治疗的52例肝内胆管结石合并肝内胆管癌病人的临床病理资料,并对临床病理结果及预后进行统计分析。应用Kaplan-Meier法描绘生存曲线,Cox回归模型分析影响其预后的因素。结果 GPS是肝内胆管结石合并肝内胆管癌病人术后总体生存的独立危险因素。GPS评分为2的病人其淋巴转移(P=0.029)和肿瘤为Ⅲ-Ⅳ期比例大(P=0.007)。结论 GPS评分是肝内胆管结石合并肝内胆管癌病人肝切除术后预后的独立危险因素。 Objective To explore the association between preoperative glasgow prognostic score( GPS) and prognosis in hepatolithiasis-associated intrahepatic cholangiocarcinoma( HLAIHCC) patients underwent liver resection. Methods Clinical data of 52 consecutive HLAIHCC patients who underwent hepatectomy were retrospectively reviewed. The clinical and pathological date and prognosis was analyzed. The curves of overall survival were depicted using the Kaplan-Meier method. Cox proportional hazard models tested the associations between variables and prognosis. Results GPS was an independent risk factor of overall survival of IHHCC. Patients with a GPS 2 had more lymph node metastasis( P = 0. 029) and more TMN Ⅲ-Ⅳ( P = 0. 007). Conclusions GPS is an independent risk factor of prognosis of HLAIHCC patients who underwent liver resection.
出处 《肝胆外科杂志》 2017年第5期345-348,共4页 Journal of Hepatobiliary Surgery
基金 温州市科技局基金资助(项目编号:Y20160143)
关键词 肝内胆管结石 肝内胆管癌 GPS评分 肝切除 预后因素 hepatolithiasis intrahepatic cholangiocarcinoma glasgow prognostic score liver resection prognostic factor
  • 相关文献

参考文献1

二级参考文献13

  • 1Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014,64(1) :9.
  • 2Dreanic J, Maillet M, Dhooge M, et al. Prognostic value of the Glasgow Prognostic Score in metastatic colorectal cancer in the era of anti- EGFR therapies. Med Oncol,2013,30(3) :656.
  • 3Lamb G W, Aitchison M, Ramsey S, et al. Clinical utility of the Glasgow Preglaostic Score in patients undergoing curative nephreetomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Cancer, 2012,106(2) :279.
  • 4Linton A, Pond G, Clarke S, et al. Glasgow progosic score as a prognostic factor in metastatic castration - resistant prostate cancer treated with docetaxel - based chemotherapy. Clin Genitourin Cancer, 72013,11(4) :423.
  • 5Shafique K, Proctor M J, McMillan D C, et al. Systemic inflamma- tion and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study. Prostate Cancer Prostatic Dis, 2012,15(2) : 195.
  • 6Tomita M, Ayabe T, Chosa E, Nakmnura K. Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non - small cen lung cancer. Anticancer Res, 2014,34( 6 ) : 3137.
  • 7Umihanic S, Umihanic S, Jamakosrnanovic S, et al. Glasgow prognostic score in patients receiving chemotherapy for non - small - cell lung cancer in stages IIIb and IV. Med Arch, 2014,68(2):83.
  • 8Martin H L, Ohara K, Kibem A,et al. Pmgrtostic value of systemic in- flammation - based markers in advanced pancreatic cancer. Intern Meal J,2014,44(7) :676.
  • 9Juan H, Qijun W, Jmdan L. Serum CRP protein as a differential mark- er in cancer. Cell Biochem Biophys,2012,64(2):89.
  • 10Sejima T, Iwamoto H, Massago T, et 81. Low pre - operative levels of serum albumin predict lymph node metastases and ultimately correlate with a biochemical recurrence of prostate cancer in radical pmstatecto- my patients. Cent European J Uml,2013,66(2) : 126.

共引文献1

同被引文献24

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部